Abstract:Objective: Mutations in members of the cytoskeletal intermediate filament proteins (IFs), keratin polypeptides 8 and 18 (K8/K18), predispose their carriers to acute and chronic liver disease progression.Keratin associated diseases are among .70human diseases that are caused or predisposed to by IF mutations, with the defining feature in many of these diseases being disruption of the normal IF organization within the cytoplasm.In contrast to microfilaments and microtubules, no drugs are available for IFs that can modulate their organization and potentially provide a sorely lacking therapy.Methods: We used an imagingbased drug screening platform consisting of lung carcinoma A549 cells transduced with lentiviruses containing GFP-tagged K18 R90C and wild-type K8.The cells were screened against several compound libraries, and a select compound was further tested in cell culture and in livers of mice that express mutant K18 in order to define its mechanism of action.Results: Screening of a 320-compound kinase inhibitor library showed that the inhibitors of protein kinase C (PKC) and tyrosine kinases, particularly MIDOSTAURIN, led to significant correction of the defective organization of K18 R90C puncta towards normal filaments after 24 h with a maximal effect at 48 h.The findings were confirmed using multiple MIDOSTAURIN concentrations and in another cell line, Hacat, that expresses mutant K14.While MIDOS-TAURIN diminished the expression of the mutant keratin 14 in Hacat cells, the effect in the A549 cells was independent of K18 expression but causes changes in K18 phosphorylation that are known to regulate filament formation.MIDOSTAURIN significantly prevented interferon and FAS ligand-induced apoptosis in A549 cells.The protective effect occurs after 48 h but not after 1 h treatment with MIDOSTAURIN, suggesting that the drug effect is more likely to be related to the correction of filament organization.In mice, administration of MIDOSTAURIN is well tolerated and its administration prior to exposure to FAS results in dramatic protection from liver injury.Conclusion: The kinase inhibitor MIDOSTAURIN alleviates cytoskeletal structural defects caused by K18 R90C mutation and also protects from apoptosis in cultured and in the livers of mice exposed to FAS ligand.MIDOSTAURIN may be a potential therapeutic for IF diseases and, notably, it is presently undergoing clinical trials in patients with acute myeloid leukemia and gastrointestinal stromal tumors.

Mutation of human keratin 18 in association with cryptogenic cirrhosis.

Keratin 8 And 18 Mutations Are Risk Factors For Developing Liver Disease Of Multiple Etiologies

Absence of keratin 8 or 18 promotes antimitochondrial autoantibody formation in aging male mice

Expression of an epidermal keratin protein in liver of transgenic mice causes structural and functional abnormalities.

A Novel Mutation Within the 2B Rod Domain of Keratin 9 in a Chinese Pedigree with Epidermolytic Palmoplantar Keratoderma Combined with Knuckle Pads and Camptodactyly

Keratin Variants Are Overrepresented in Primary Biliary Cirrhosis and Associate with Disease Severity

Mutation Analysis of Novel Human Liver-Related Putative Tumor Suppressor Gene in Hepatocellular Carcinoma

Mo1772 Kinase Inhibition Normalizes Mutation-Mediated Keratin Filament Disruption and Predisposition to Apoptosis and Liver Injury

Mo1775 Epigenetic Inactivation of Claudin 3 in Hepatocellular Carcinoma and Its Functional Consequences

Analysis of Keratin Polypeptides 8 and 19 Variants in Inflammatory Bowel Disease

Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex

Mice expressing a mutant Krt75 (K6hf) allele develop hair and nail defects resembling pachyonychia congenita

A Novel Mutation of the Keratin 1 Gene in a Family with Epidermolytic Hyperkeratosis

PKC412 Normalizes Mutation‐related Keratin Filament Disruption and Hepatic Injury in Mice by Promoting Keratin–myosin Binding

Keratin 17 mutation in pachyonychia congenita type 2 in a Chinese Han family

Mutation Analysis of Keratin 9 Gene in a Pedigree with Epidermolytic Palmoplantar Keratoderma

Keratin 17 in disease pathogenesis: from cancer to dermatoses: Keratin 17 in disease pathogenesis

Keratin 17 null mice exhibit age- and strain-dependent alopecia

Impact of Keratins 8 and 18 Genetic Variants on the Severity of Alcoholic Liver Disease

The keratin 16 null phenotype is modestly impacted by genetic strain background in mice

Keratin 8 absence down-regulates colonocyte HMGCS2 and modulates colonic ketogenesis and energy metabolism